These efforts should be documented on the appropriate CRF page. Aduro Biotech , Inc. Protocol ADU -CL-02-v8 CRS -207 with Pemetrexed and Cisplatin Version 8, 08 March 2018 Page 62 8.0 DATA COLLECTION AND PROCESSING AND STATISTICAL ANALYSIS 8.1 DATA COLLECTION AND PROCESSING CRFs will be used to capture study results and data. The study coordinator or other authorized study personnel will transcribe data from source documents onto paper or electronic CRFs. All CRFs will be reviewed and source verified by the study monitor during periodic site visits, and the study monitor will ensure that all data in the CRF are correct and complete. Before or b etween visits, the medical monitor or study monitor may request copies of the CRFs for preliminary medical review. Once the CRFs are complete and source- verified, the investigator must sign and date all required pages, verifying the accuracy of all data contained within the CRF. Training will be provided on proper completion of CRFs. If electronic CRFs are used, training will be provided for the electronic data capture (EDC) system. All personnel using the EDC system must have appropriate education, training, and experience. The investigator will be provided with standard operating procedures (SOPs) (contained in the SPM or a vendor- specific SOP) on the use of the EDC system. The investigator will be responsible for documenting employee education, training, and previous experience that pertains to the EDC system. The investigator must maintain adequate security of the EDC system, including documentation that all users have been trained on the appropriate SOPs and a list of authorized users. To ensure attributability, all personnel responsible for data entry must obtain a unique electronic signature before any data can be entered in the CRFs. The system must be configured to ensure that the signer cannot readily repudiate the signed record as not genuine. Authorized study personnel will be assigned a unique password and associated electronic signature after receiving SOP training. If EDC systems other than those provided and maintained by the sponsor are used for documentation and data capture, the inv estigator must ensure that the systems are validated and ensure data backup as described in Section 9.2. Aduro Biotech , Inc. Protocol ADU -CL-02-v8 CRS -207 with Pemetrexed and Cisplatin Version 8, 08 March 2018 Page 63 8.2 STATISTICAL ANALYSIS 8.2.1 General Overview The data will be summarized in tables listing the mean, standard deviation, median, minimum, maximum an d number of subjects in a group for continuous data; in tables listing count and percentage for categorical data; and median and standard error for time -to-event data. Data will be listed for each subject.